SCHEMBL21591946

SCHEMBL21591946

O=C(Nc1ccc(Cl)nc1OCC(F)(F)F)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 3/20 0.37
GSK3B P49841 3/20 0.37
CNR2 P34972 1/20 0.36
MRGPRX1 Q96LB2 1/20 0.36
XPO1 O14980 1/20 0.34
MEN1 O00255 3/20 0.34
LMNA P02545 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SMARCA2 P51531 1/20 0.34
SMARCA4 P51532 1/20 0.34
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
KCNE1 P15382 1/20 0.34
KCNQ1 P51787 1/20 0.34
S1PR2 O95136 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17490444 0.86 IAPP (0.44) GSK3AGSK3BCNR2MRGPRX1XPO1
SCHEMBL2718290 0.74 L3MBTL1 (0.43) GSK3AGSK3BCNR2XPO1MEN1
SCHEMBL28347645 0.74 AR (0.35) CNR2
SCHEMBL2714081 0.74 TUBB4A (0.43) CNR2XPO1LMNAMAPTSMN1; SMN2
SCHEMBL31263190 0.74 SMN1; SMN2 (0.37) XPO1MEN1LMNAKMT2AMAPT
SCHEMBL2525732 0.73 MAPT (0.41) GSK3BCNR2XPO1MEN1LMNA
SCHEMBL23040192 0.70 PDK1 (0.41) XPO1MEN1LMNAKMT2AMAPT
SCHEMBL29499821 0.70 PDK1 (0.41) XPO1MEN1LMNAKMT2AMAPT
SCHEMBL29389622 0.70 IAPP (0.42) GSK3AGSK3BCNR2LMNAMAPT
SCHEMBL24251812 0.70 IAPP (0.42) GSK3AGSK3BCNR2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638897-B EGFR kinase inhibitor and preparation method and application thereof 上海艾力斯医药科技股份有限公司 2024-03-01 CN disclosed
CN-110606842-B Process for producing pyridylamino pyrimidine derivative and intermediate thereof 上海艾力斯医药科技股份有限公司 2021-06-01 CN disclosed
CN-112638897-A EGFR kinase inhibitor and preparation method and application thereof 上海艾力斯医药科技股份有限公司 2021-04-09 CN disclosed
CN-110857292-A EGFR kinase inhibitor and preparation method and application thereof 上海艾力斯医药科技有限公司 2020-03-03 CN disclosed
WO-2020038433-A1 EGFR KINASE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 上海艾力斯医药科技有限公司 2020-02-27 WO disclosed
CN-110606842-A Process for producing pyridylamino pyrimidine derivative and intermediate thereof 上海艾力斯医药科技有限公司 2019-12-24 CN disclosed
WO-2019238103-A1 PREPARATION METHOD FOR PYRIDINYLAMINOPYRIMIDINE DERIVATIVE AND INTERMEDIATE THEREOF 上海艾力斯医药科技有限公司 2019-12-19 WO disclosed
WO-2019238103-A1 PREPARATION METHOD FOR PYRIDINYLAMINOPYRIMIDINE DERIVATIVE AND INTERMEDIATE THEREOF 上海艾力斯医药科技有限公司 2019-12-19 WO disclosed